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Summary
Background Malaria is a major cause of morbidity and mortality in Africa. International eﬀ ort and funding for control 
has been stepped up, with substantial increases from 2003 in the delivery of malaria interventions to pregnant women 
and children younger than 5 years in The Gambia. We investigated the changes in malaria indices in this country, and 
the causes and public-health signiﬁ cance of these changes.
Methods We undertook a retrospective analysis of original records to establish numbers and proportions of malaria 
inpatients, deaths, and blood-slide examinations at one hospital over 9 years (January, 1999–December, 2007), and at 
four health facilities in three diﬀ erent administrative regions over 7 years (January, 2001–December, 2007). We 
obtained additional data from single sites for haemoglobin concentrations in paediatric admissions and for age 
distribution of malaria admissions.
Findings From 2003 to 2007, at four sites with complete slide examination records, the proportions of malaria-positive 
slides decreased by 82% (3397/10861 in 2003 to 337/6142 in 2007), 85% (137/1259 to 6/368), 73% (3664/16932 
to 666/11333), and 50% (1206/3304 to 336/1853). At three sites with complete admission records, the proportions of 
malaria admissions fell by 74% (435/2530 to 69/1531), 69% (797/2824 to 89/1032), and 27% (2204/4056 to 496/1251). 
Proportions of deaths attributed to malaria in two hospitals decreased by 100% (seven of 115 in 2003 
to none of 117 in 2007) and 90% (22/122 in 2003 to one of 58 in 2007). Since 2004, mean haemoglobin concentrations 
for all-cause admissions increased by 12 g/L (85 g/L in 2000–04 to 97 g/L in 2005–07), and mean age of paediatric 
malaria admissions increased from 3·9 years (95% CI 3·7–4·0) to 5·6 years (5·0–6·2). 
Interpretation A large proportion of the malaria burden has been alleviated in The Gambia. Our results encourage 
consideration of a policy to eliminate malaria as a public-health problem, while emphasising the importance of 
accurate and continuous surveillance.
Funding UK Medical Research Council.
Introduction
Malaria is a major public-health problem in Africa, 
including The Gambia where it has been one of the main 
causes of mortality and morbidity in children younger 
than 5 years,1 pregnant women,2 and non-immune 
visitors.3 Investigations into ways to control malaria have 
been undertaken in The Gambia for more than 50 years.4 
Early studies showed that chemoprophylaxis was highly 
eﬀ ective in reduction of clinical attacks in children.5 A 
later trial of seasonal chemoprophylaxis with Maloprim 
(pyrimethamine and dapsone) administered by village 
health workers showed a reduction in morbidity from 
malaria, and a decrease in overall mortality in children 
younger than 5 years of more than 30%, emphasising the 
importance of malaria as a cause of death in children in 
The Gambia.6 These ﬁ ndings were conﬁ rmed by 
subsequent trials of insecticide-treated bednets, which 
showed substantial reductions in malaria-related 
morbidity7 and mortality8,9 in children.
Insecticide-treated bednets, prompt and eﬀ ective 
treatment of clinical cases of malaria, intermittent 
preventive treatment in pregnant women and, in some 
populations, indoor residual spraying are now being 
deployed widely across Africa, with increasing amounts 
of coverage achieved.10 These initiatives follow more 
eﬀ ective advocacy and support from the 
Bill & Melinda Gates Foundation, WHO, and public–
private partnerships, and have been led by programmes 
such as the Global Fund to ﬁ ght AIDS, Tuberculosis and 
Malaria and the Roll Back Malaria partnership, which 
have both contributed to substantially increased pro-
vision of insecticide-treated bednets in The Gambia 
since 2003. Further more, programmes such as the 
President’s Malaria Initiative have supported control in 
other African countries.11 
However, whether most aﬀ ected communities12—who 
generally have inadequate surveillance of malaria—have 
beneﬁ ted, is not yet clear.13 Published data are mostly 
from the fringes of endemic areas. Highly organised 
programmes for indoor residual spraying have 
substantially reduced malaria in South Africa and 
neighbouring areas of Mozambique and Swaziland,14 
and separately on the island of Bioko in 
Equatorial Guinea.15 In Eritrea, a major fall in morbidity 
and mortality from malaria has been attributed to use of 
indoor residual spraying together with distribution of 
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insecticide-treated bednets and strengthening of malaria 
case management in the community.16 A reduction in 
malaria on the island of Zanzibar occurred after highly 
eﬀ ective artemisinin-based combination therapy was 
introduced, and was consolidated after increased 
distribution of insecticide-treated bednets.17 In Kenya, 
the number of malaria admissions has fallen in the 
coastal area,18 and reduced risk has been attributed to 
increasing use of such bednets as a result of social 
marketing and free distribution.19 Short survey visits 
suggest that malaria might be decreasing in other 
countries in which interventions have increased,20,21 but 
there are few data from West Africa, where a large 
proportion of global malaria cases arise.22 
We undertook a retrospective analysis to investigate the 
changes that have occurred in The Gambia over the 
past 9 years, their potential causes, and public-health 
signiﬁ cance.
Methods
Study site and population
The Gambia is situated on the Atlantic coast of west 
Africa at the interface of the Sudan Savannah and 
northern Guinea Savannah zones. The country has one 
short rainy season from June to October, and most 
malaria transmission occurs between August and 
December.23 Almost all clinical cases of malaria are due 
to Plasmodium falciparum, which is transmitted by three 
species of the Anopheles gambiae complex.24 Patterns of 
malaria in three of the ﬁ ve diﬀ erent administrative 
regions of The Gambia have been surveyed at ﬁ ve health 
facilities, in which we identiﬁ ed high quality and 
continuous records (ﬁ gure 1). In the Western Region, we 
obtained data for three facilities: Medical Research 
Council (MRC) hospital in Fajara (ward admissions, 
deaths, and outpatient haematology laboratory data); 
WEC (Worldwide Evangelisation for Christ) mission 
hospital in Sibanor (ward admissions, number of blood 
transfusions, haemoglobin concentration, and deaths); 
and the Government Major Health Centre in Brikama 
(haematology laboratory data). In the Lower River Region, 
we obtained laboratory haematology data from the MRC 
Keneba Clinic that serves the surrounding villages. In 
the North Bank Region, we gathered records for paediatric 
ward admissions and haematology laboratory data from 
the AFPRC (Armed Forces Provisional Ruling Council) 
District Hospital in Farafenni, which is the second largest 
hospital in the country. 
Data collection
We examined hospital and laboratory records for 9 years 
from January, 1999, to December, 2007. The MRC Scientiﬁ c 
Co-ordinating Committee and the Joint MRC and 
Gambian Government Ethical Committee reviewed and 
approved the design of the data collection and analysis. 
The study was undertaken in two consecutive phases.
In phase 1, data were collected from the complete series 
of admission books at the MRC Fajara ward to enumerate 
the numbers of all admissions, admissions of malaria 
cases, all deaths, and deaths that were attributed to 
malaria. We also collected data from the complete series 
of laboratory books of the MRC outpatient haematology 
laboratory to enumerate the number of slides read and 
the number that were positive for malaria parasites. 
Throughout the study period, a thick blood ﬁ lm 
examination (with Field’s staining) was done routinely 
for all patients attending the outpatient clinic for 
consultation with a physician, after screening by a nurse 
for fever and other signs and symptoms including 
headache and vomiting that are commonly, but not 
speciﬁ cally, associated with clinical malaria. Routine 
examination was undertaken on 100 high-power ﬁ elds 
(×1000 magniﬁ cation) of every slide to identify parasites.
In phase 2, data were subsequently collected for 
7 years from January, 2001, to December, 2007, from 
additional facilities (Brikama, Sibanor, Farafenni, and 
Keneba), which all have established links with the MRC 
for laboratory quality assurance and training. We designed 
a standard form to count the total number of overall 
admissions and number of admissions attributed to 
malaria every month, date of admission, and patient 
information such as age, sex, nationality, clinical 
diagnosis, and outcome. Clinical data for all patients 
admitted at the health facilities that we surveyed had been 
recorded in standard medical record books, which were 
kept at the wards of each facility by trained experienced 
ﬁ eld workers and nurses in charge of the health facilities. 
We designed a second form to count numbers of slides 
examined and malaria-positive slides every month.
Malaria was managed as described in the clinical 
protocols of the national guidelines for clinical manage-
ment in The Gambia. The ﬁ rst-line treatment for mild 
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Figure 1: Location of the ﬁ ve sites studied for hospital admissions, inpatient deaths, and laboratory slide 
microscopy in The Gambia
The facilities at Fajara and Brikama serve mostly urban and peri-urban communities in the most densely populated 
part of the country near the coast; Farafenni is a small town with a large hospital serving a predominantly rural 
population; and facilities at Sibanor and Keneba are in large villages serving surrounding rural communities.
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malaria was chloroquine until the end of 2004, when a 
change was made to a combination of chloroquine and 
sulfadoxine plus pyrimethamine. Quinine is used as 
ﬁ rst-line treatment for severe malaria cases. In 2005, a 
policy decision was made for a future change of ﬁ rst-line 
malaria treatment to Coartem (artemether plus lume-
fantrine), which was subsequently supported by an award 
from the Global Fund Round 6. At the end of 2007, 
training and logistics were launched for introduction of 
Coartem at health facilities during 2008.
Monthly rainfall data for the study period were available 
from three meteorological stations in the Greater Banjul 
Area (Banjul, Serrekunda, and Yundum), and we averaged 
the results from these stations. Data for coverage of 
malaria-control interventions including insecticide-
treated bednets were available from the multiple indicator 
cluster surveys (MICS),25,26 which were undertaken in all 
regions of The Gambia in 2000 (May–June) and 
2006 (started in December, 2005, but mostly done between 
January and March, 2006). Both surveys coincided with 
the long dry season in the respective years when malaria 
would have been fairly infrequent, and net use by 
individuals might have been slightly less than in the rainy 
season when mosquitoes would be most abundant.
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Figure 2: Monthly numbers (left panel) and yearly proportions (right panel) of malaria hospital admissions (A), deaths (B), and positive slides in outpatients (C) at the MRC in Fajara from 
January, 1999, to December, 2007
Monthly and yearly rainfall in the Greater Banjul Area over the period is also shown (D). Error bars indicate 95% CIs. 
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Serology 
We assayed serum samples from a cohort study (not yet 
published) of infants born in Sukuta (Western Health 
Region) between July, 2003, and February, 2004, to 
investigate the acquisition of antibodies to blood stage 
P falciparum antigens during the ﬁ rst 3 years of life. This 
peri-urban community located between Fajara and 
Brikama was selected for study because it previously had 
an incidence of malaria that was representative of many 
Gambian communities in the Western Region27,28 and it is 
the only site in the country with a continuous birth cohort, 
which was recruited to study responses to infant vaccines. 
The samples that we used in this study were collected as 
part of a subcohort study of measles vaccine responses, 
and we undertook the assay of malaria antibodies after 
review and approval by the MRC Scientiﬁ c Co-ordinating 
Committee and the Joint MRC and Gambian Government 
Ethical Committee. IgG reactivity to the whole ectodomain 
of Apical Membrane Antigen 1 (AMA1) and to the 
19 kilodalton C-terminal part of merozoite surface 
protein 1 (MSP1-19) was measured by ELISA in sera that 
were obtained from 53 children at birth (cord blood) and 
at 4, 9, 18, and 36 months of age. The assay protocols have 
been previously described in studies of endemic 
populations.29,30
Statistical analysis
Clinical and laboratory data collected from record books 
from health facilities were given to the investigator who 
was responsible for data management (IA). Data were 
double entered and validated into a Microsoft Access 
database. A clean database was generated and converted 
into Stata (version 9) format with use of Stat Transfer 
(version 8). We analysed data using Stata (version 9). We 
calculated proportions and mean values with 95% CIs on 
the estimates as population samples, and risk ratios (RR) 
with 95% CIs to show diﬀ erences in proportions between 
discrete time periods. We assessed the signiﬁ cance of 
diﬀ erences in the proportions of malaria cases, malaria 
deaths, and positive slides over time by χ2 tests for trend. 
Linear regression was also applied to log transformed 
data from Fajara to test the signiﬁ cance of decreases over 
diﬀ erent periods.
Role of the funding source
The sponsor of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication. 
Results
During the 9 years from January, 1999, to December, 2007, 
21 820 patients were admitted to the MRC hospital in 
Fajara, 1341 inpatients died, and 129 397 slides were 
examined at the outpatient haematology laboratory. Every 
year, the number of admissions attributed to malaria, 
deaths attributed to malaria, and positive slides showed a 
highly seasonal distribution, with a peak from September 
to November at the end of the rainy season and with few 
cases during the driest months of the year (ﬁ gure 2). 
During the study period, we detected a substantial decrease 
in the yearly number of admissions and deaths attributed 
to malaria and malaria-positive slides, particularly 
since 2003 (ﬁ gure 2). 2002 had an unusually low yearly 
rainfall and a low number of cases of malaria, which is a 
normal pattern of inter-year variation, but the reduction 
since 2003 was not related to any decrease in yearly rainfall 
(ﬁ gure 2). 
Compared with 2003, we recorded a 74% reduction in 
the proportion of malaria cases admitted in 2007 
(435/2530 in 2003 vs 69/1531 in 2007; RR 0·26 [95% 
CI 0·20–0·34]), a 100% reduction in the proportions of 
deaths attributed to malaria (seven of 115 vs none of 117; 
p=0·006), and a 73% reduction in the proportion of 
slides positive for malaria (3664/16 932 vs 666/11 333; 
RR 0·27 [0·25–0·29]) at the MRC in Fajara (ﬁ gure 2). 
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Figure 3: Age distribution of malaria cases admitted to the MRC ward from 
April, 1999, to December, 2007
(A) Mean age of paediatric cases (≤ 15 years) of malaria in every year from 
1999 to 2007. Bars represent mean and error bars 95% CI. (B) Proportion of 
paediatric cases (≤ 15 years) of malaria in every age class in 1999–2000 
and 2005–07. 
Figure 4: Monthly numbers (left panel) and yearly proportions (right panel) 
of malaria hospital admissions in Sibanor (A) and Farafenni (B); malaria 
mortality in Sibanor (C); and malaria-positive slides in Brikama (D) and 
Keneba (E) from January, 2001, to December, 2007, and in Farafenni (F) from 
January, 2003, to December, 2007
Error bars indicate 95% CIs.
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Regression analysis for the whole 1999–2007 data series 
suggests that until 2003, there was no linear decrease in 
positive slides or malaria admissions, although the 
reduction in malaria deaths was signiﬁ cant, whereas all 
these indices fell substantially and signiﬁ cantly 
after 2003 (webﬁ gure and webtable). The number of 
deaths attributed to malaria had already fallen sharply 
in 2002, increased only slightly in 2003, and then 
decreased to the lowest levels ever recorded (only one 
case of malaria with a fatal outcome was admitted in 
the last 2 years of the study period).
The age of malaria admissions in children (up to 
15 years of age) at the MRC ward has signiﬁ cantly 
increased since 2004 (ﬁ gure 3), suggesting that the 
reduction in malaria has been greatest in younger 
children. The mean age shifted from 3·9 years 
(95% CI 3·7–4·0) in 1999–2003 to 5·6 years (5·0–6·2) in 
2005–07 (ﬁ gure 3). The age distribution at the beginning 
of the study period (1999–2000) was strongly skewed 
towards very young children compared with the end of 
the period (2005–07) when the distribution was ﬂ atter 
and the proportions of children older than 5 years had 
signiﬁ cantly increased (ﬁ gure 3). 
In four other health facilities that we investigated over 
the 7 years from January, 2001, to December, 2007, 
complete admissions data were available from Sibanor 
(14 877 all-cause admissions) and Farafenni (21 050 all-
cause admissions); data for attributed cause of death 
were also available from Sibanor (716 all-cause inpatient 
deaths). Reliable and continuous records of slide 
examinations were available over the whole study period 
from Brikama (55 486 slides examined), Keneba 
(5768 slides examined), and for the last 5 years from 
Farafenni (12 513 slides examined) (ﬁ gure 4). 
All data sets show the same seasonal peaks that were 
present in Fajara, and show large and highly signiﬁ cant 
decreases in the numbers and proportions of malaria 
cases, deaths, and positive slides since 2003 (ﬁ gure 4). 
The 69% reduction in proportions of admissions 
attributed to malaria in Sibanor (797/2824 in 2003 
vs 89/1032 in 2007; RR 0·31 [95% CI 0·25–0·38]) was 
more pronounced than was the 27% decrease in Farafenni 
(2204/4056 vs 496/1251; RR 0·73 [0·68–0·79]) (ﬁ gure 4). 
As we noted in Fajara, mortality from malaria in Sibanor 
has almost disappeared (only one death from malaria 
was recorded at Sibanor hospital in the last 2 years of the 
study period) (ﬁ gure 4).
Since 2003, the 82% decrease in proportions of slides 
that were positive for malaria parasites in Brikama 
(3397/10861 in 2003 vs 337/6142 in 2007; RR 0·18 [95% 
CI 0·16–0·20]), and the 85% reduction in the proportions 
that were positive in Keneba (137/1259 vs six of 368; 
RR 0·15 [0·07–0·34]) (ﬁ gure 4), were even greater than 
was the reduction noted at Fajara (ﬁ gure 2). In Farafenni, 
the proportion of malaria-positive slides has been halved 
(1206/3304 vs 336/1853; RR 0·50 [0·45–0·55]). 
Maternally derived antibodies to the P falciparum blood 
stage antigens AMA1 and MSP1-19 fell rapidly in the 
53 children born in Sukuta in 2003–04, and almost all 
infants were antibody negative for MSP1-19 by the fourth 
month and for AMA1 by the ninth month of life (children 
had higher starting levels against AMA1) (ﬁ gure 5). 
At 18 months of age, two (4%) children had antibodies to 
AMA1 and MSP1-19; by 36 months of age, only two (4%) 
and three (6%) children were positive to these antigens, 
respectively (ﬁ gure 5). 
During the 8 years from December, 1999, to 
November, 2007, 18 906 patients were admitted to the 
hospital in Sibanor. 9763 (52%) of these patients were 
younger than 5 years, and haemoglobin values were 
available for 7408 cases. We noted that a major trough in 
haemoglobin concentrations coincided with the end of 
the rainy season (ﬁ gure 6), which is attributable to a 
combination of seasonal malaria and nutritional 
deﬁ ciency during a so-called hungry season before most 
crops are harvested; however, we noted a substantial 
increase in haemoglobin values from 2004 onwards. 
We recorded a mean diﬀ erence of 12·4 g/L (95% CI 
10·6–13·8; p<0·0001) in haemoglobin concentration in 
patients who were admitted to the health facilities 
before 2004 (mean 84·9 [SD 11·0] g/L) and after 2004 
(97·3 [9·3] g/L); from this point on, the magnitude and 
timing of the seasonal trough has become less clear. 
The eﬀ ect on admission of severe anaemia and inpatient 
care is indicated by the yearly proportions of children 
younger than 5 years needing transfusion (ﬁ gure 6). 
The decrease in the number of children needing 
transfusion (p<0·0001) has been so profound that 
during 2007, the hospital management decided to 
discontinue transfusion services and transfer the few 
patients with severe anaemia to other hospitals. The 
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Figure 5: Proportion of maternally derived antibodies and frequency of new responses to malaria antigens in 
children born in 2003–04 
The plot shows the percentage seropositive for IgG to the merozoite antigens AMA1 and MSP1-19 in 
53 children at birth and at 4, 9, 18, and 36 months of age. The cut-oﬀ  values for positivity were the mean 
plus 3 SD of ELISA OD (optical density) levels for 20 sera obtained from non-exposed individuals.
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transfusion criteria did not change over the period 
studied, during which a typical threshold of haemoglobin 
concentration less than 45 g/L was applied and 
transfusion compliance was very high. Furthermore, we 
noted no change in concern about infection risk that 
might have modiﬁ ed transfusion rates over this time, 
during which community prevalence rates of HIV 1 
and 2 were low (<2%).
The table shows data from the two most recent 
MICS surveys. Between 2000 and 2006, we recorded a 
more than three-fold increase in the proportion of 
children who slept under an insecticide-treated bednet, 
and an almost ten-fold increase in the proportion of 
pregnant women who received appropriate intermittent 
preventive treatment. The proportion of children reported 
to have had a fever in the 2 weeks before interview was 
almost halved between these two surveys (table).
Discussion
During the past few years, eﬀ orts to control malaria in 
Africa have expanded to a level that has not been seen 
since the time of the malaria eradication programme 
50 years ago. In The Gambia, we recorded changes at all 
ﬁ ve facilities studied, particularly since 2003. We noted a 
progressive reduction in the proportions of ward 
admissions and deaths attributed to malaria, and of 
positivity rates of outpatient malaria slides. Actual 
numbers have decreased even more substantially, since 
admissions attributed to other causes and total numbers 
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Figure 6: Rate of anaemia in children younger than 5 years who were admitted to Sibanor health facilities 
Data are from 7408 children from 2000 to 2007. (A) Monthly mean haemoglobin concentrations of patients. The months of the yearly malaria seasons 
(August–December) are marked with blue shading. (B) Percentage of children receiving blood transfusion every year from 2000 to 2007. 
2000 2006 Risk ratio (95% CI)* p value
Children younger than 5 years
Had febrile illness during 2 weeks before the 
survey 
14·8% 8·4% 0·57 (0·51–0·63) <0·001
Slept under an ITN the night before the survey 14·5% 49·0% 3·38 (3·11–3·67) <0·001
Slept under any net the night before the survey 41·8% 63·0% 1·51 (1·44–1·57) <0·001
Women
Received two doses of SP (IPT) during last 
pregnancy
(3·4%)† 32·5% 9·56 (undeﬁ ned) Undeﬁ ned
ITN=insecticide-treated bednet. SP=sulfadoxine plus pyrimethamine. IPT=intermittent preventive treatment. 
*95% CIs could be calculated for the data for children younger than 5 years because sample sizes were available 
(N=3632 in 2000; N=6543 in 2006),25,26 but not for the data for IPT in women. †IPT in pregnant women was not 
reported in the 2000 MICS survey (the ﬁ gure in parentheses is from an unpublished survey in 2002). 
Table: Changes in coverage of malaria interventions and febrile illness between 2000 and 2006, shown 
in multiple indicator cluster surveys (MICS) in The Gambia 
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of slides examined have also slightly decreased. Previous 
trials of chemoprophylaxis and insecticide-treated bednets 
against malaria in The Gambia have shown reductions in 
all-cause morbidity and mortality greater than that directly 
attributable to malaria.8,31 Furthermore, evidence suggests 
that malaria can have a major indirect contribution to the 
comorbidities from other infectious diseases,32 although 
our study was not designed to test this hypothesis. The 
potentially complex relations between common infectious 
diseases in children need to be better understood now 
that malaria is substantially decreasing. 
Data from health facilities do not always represent 
disease trends in the general population. For this 
retrospective study, we considered it important that data 
for malaria blood slides were obtained only from 
laboratories with trained staﬀ  and continuously 
monitored laboratory procedures in place. Similarly, data 
for hospital admissions were gathered from well 
established health facilities serving populations that 
might be able to access interventions to prevent malaria. 
Thus, we cannot assume that our ﬁ ndings are applicable 
to the whole country. Nevertheless, all the indices that we 
measured from all the sites are concordant and very 
encouraging, which is notable since the institutional 
facilities diﬀ ered and included two government facilities, 
two MRC research sites, and a non-governmental 
organisation mission hospital, in urban and rural areas. 
Data were not available for analysis from private 
pharmacies, but discussions with retail managers 
suggested that sales of antimalarial drugs have fallen, 
which is consistent with the general perception in the 
community that the incidence of malaria has decreased. 
Recognition of the importance of prospectively collecting 
and ensuring quality of data from a systematic sample of 
facilities has led the National Malaria Control Programme 
to begin a surveillance system to detect future changes, 
incorporating one major government health centre in 
each administrative district in the country. 
Other means of investigating changes in malaria in the 
population should also be considered, especially since 
high-quality surveillance is still almost universally absent 
from areas where malaria is most common. The nationally 
collected MICS data indicate a 43% reduction between 2000 
and 2006 in episodes of fever reported by parents in 
children younger than 5 years, suggesting a substantially 
reduced malaria incidence in the community. More 
speciﬁ c measurements should be incorporated as part of 
regular community surveillance if further changes in the 
malaria endemic are to be sensitively detected. Indices for 
the entomological inoculation rate (the product of the 
sporozoite prevalence in vector mosquitoes and the 
human biting rate) are relevant for estimating 
transmission rates, but decreases are diﬃ  cult to measure 
accurately when sporozoite prevalence is already low (<1%) 
as in most previously published surveys from The 
Gambia33 and in surveys of villages in the Farafenni area 
in 2002–03 (unpublished data). 
Community surveys of parasite infection and enlarged 
spleen rates23 are informative, and serological surveys of 
whole communities can provide a practical alternative to 
infer the force of infection in a community with stable 
endemicity;34 however, these initiatives have not been 
clearly applied to changes in malaria transmission over 
time. In the peri-urban area of Sukuta that previously 
had a moderate to high endemicity that is typical of many 
Gambian communities,27,28 few children born in 2003–04 
seroconverted during the ﬁ rst 3 years of life, although 
maternally transferred antibody reactivity in most 
cord-blood samples was an indicator of substantial 
previous exposure to malaria. Serological studies of 
infants were previously used to document the local 
eradication of malaria,35 and surveys of infants and young 
children might now provide one of the more eﬀ ective 
means to quantify recent local transmission. 
We recorded a substantial shift in the mean age of 
children who were admitted to the MRC Fajara ward with 
malaria after 2004. The mean age of malaria admissions 
until 2004 was similar to that recorded 10 years 
previously,28 so our ﬁ nding of a trend towards older ages 
of malaria cases is new. A more substantial decrease of 
malaria admissions in younger children might be mainly 
due to increased use of insecticide-treated bednets, since 
this intervention is targeted to children younger than 
5 years; however, the reduction in malaria could cause 
some delay in the acquisition of immunity to 
P falciparum.28 A trial in Ghana showed that initial 
reduction in child mortality associated with the 
introduction of insecticide-treated bednets was not 
followed by an increase in child mortality in older 
children, 7 years after the intervention.36 A study in 
Burkina Faso reported similar ﬁ ndings 6 years after the 
introduction of insecticide-treated curtains.37 So far, all 
indices are towards a large improvement in public health. 
The large increase in mean haemoglobin concentration 
and major reduction in the number of children needing 
blood transfusions in Sibanor, coinciding with the 
malaria decrease from 2004 onwards, has had an eﬀ ect 
on health-service delivery locally. The closure of a 
transfusion facility because of low demand emphasises 
that more investigation of the results of the malaria 
decrease is needed at all levels. 
We have considered possible reasons for the decrease of 
malaria in The Gambia. Changes in rainfall cause some 
ﬂ uctuations in malaria from year to year, but could not 
account for the progressive reduction that we recorded 
since 2003. Socioeconomic changes and improvements 
in communications and access to education have probably 
had contributing eﬀ ects, although these factors are 
gradual and not expected to produce such a rapid change 
as we reported here at diverse sites. A change in 
chemotherapy is likely to have had a substantial role, 
although it might not have initiated the decrease. Until 
the end of 2004, chloroquine alone was used as ﬁ rst-line 
therapy for uncomplicated malaria in most health 
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facilities in The Gambia, even though parasite resistance 
to this drug had gradually increased to high levels since it 
was ﬁ rst detected in 1987.38 The decreasing therapeutic 
eﬃ  cacy of chloroquine could have resulted in an increase 
in outpatient treatment failure of clinical malaria cases, 
and thus an increased risk of disease for which the patient 
needs to be admitted to hospital.39 At the beginning 
of 2005, sulfadoxine plus pyrimethamine combined with 
chloroquine was adopted for ﬁ rst-line treatment in 
government health facilities, but it had been prescribed in 
a few independent facilities previously. Although the 
eﬃ  cacy of sulfadoxine plus pyrimethamine has fallen in 
east Africa because of resistance to this combination, it is 
still quite highly eﬀ ective in The Gambia when combined 
with chloroquine.40 Its use in presumptive therapy 
together with the long plasma half-lives of its components 
means that it might also have some eﬀ ect in prevention 
of infection.
The most substantial change in measures to prevent 
malaria has been the increase of coverage of 
insecticide-treated bednets, with MICS data showing a 
more than three-fold increase to 49% reported coverage 
of children younger than 5 years between 2000 and 2006. 
This initiative was possible because of support from the 
Global Fund—awarded in 2003 and implemented from 
2004 onwards—for free distribution of insecticide-treated 
bednets to women who are pregnant and mothers of 
children younger than 5 years in the Western Health 
Region (which incorporates 55% of the population; three 
of the health facilities that we studied were in this area). 
Additionally, nationwide re-treatment of bednets was 
undertaken in 2003 and 2005 with support from UNICEF 
and WHO. The Gambia now has the highest reported 
coverage of insecticide-treated bednets for children 
younger than 5 years,10 and the intended beneﬁ cial eﬀ ect 
is consistent with our ﬁ ndings. 
These ﬁ ndings support the proposal that increased 
investment in malaria interventions in Africa can have a 
major eﬀ ect on reducing morbidity and mortality from 
this disease. A large reduction might be more achievable 
in areas where transmission is highly seasonal as in 
The Gambia, than in areas that have more perennial 
transmission; however, this hypothesis has not been 
proven. Adequate data are needed from many other 
countries to identify whether this change is being 
achieved broadly throughout Africa, to allow monitoring 
and sustaining of reduced incidence where it has 
occurred, and appropriate targeting of resources to 
countries with the greatest need.11 A renewed call for 
eradication of malaria41 is being debated worldwide, but 
the epidemiological transition has encouraged the 
Gambian Government to launch a policy in February, 
2008, that malaria should be eliminated as a public-health 
problem. The means to achieve this policy are still 
unknown in any continental African country, but 
intended eﬀ orts in The Gambia include introduction 
of free artemisinin-based combination therapy 
(artemether-lumefantrine) at health centres, and indoor 
residual spraying with dichlorodiphenyltrichloroethane 
in some areas. These and other interventions could 
further reduce malaria, and eﬀ orts should now tackle 
challenges to eﬀ ective delivery and establishment of 
sustainable prospective monitoring.
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